While-alive regression analysis of composite survival endpoints
By: Xi Fang, Hajime Uno, Fan Li
Potential Business Impact:
Helps doctors understand patient health over time.
Composite endpoints, which combine two or more distinct outcomes, are frequently used in clinical trials to enhance the event rate and improve the statistical power. In the recent literature, the while-alive cumulative frequency measure offers a strong alternative to define composite survival outcomes, by relating the average event rate to the survival time. Although non-parametric methods have been proposed for two-sample comparisons between cumulative frequency measures in clinical trials, limited attention has been given to regression methods that directly address time-varying effects in while-alive measures for composite survival outcomes. Motivated by an individually randomized trial (HF-ACTION) and a cluster randomized trial (STRIDE), we address this gap by developing a regression framework for while-alive measures for composite survival outcomes that include a terminal component event. Our regression approach uses splines to model time-varying association between covariates and a while-alive loss rate of all component events, and can be applied to both independent and clustered data. We derive the asymptotic properties of the regression estimator in each setting and evaluate its performance through simulations. Finally, we apply our regression method to analyze data from the HF-ACTION individually randomized trial and the STRIDE cluster randomized trial. The proposed methods are implemented in the WAreg R package.
Similar Papers
Evaluating treatment effects on longitudinal outcomes with attrition due to death: Methods for a two-dimentional estimand with a case study in Quality of Life
Methodology
Helps doctors understand sick people's health better.
Statistical Design and Planning of an Adaptive Trial using Hierarchical Composite Outcomes: A Practical example
Methodology
Helps medical tests find medicine that works better.
Bayesian inference for cluster-randomized trials with multivariate outcomes subject to both truncation by death and missingness
Methodology
Helps doctors trust study results with missing people.